Geode Capital Management, LLC Inmune Bio, Inc. Transaction History

Geode Capital Management, LLC

  • $1.24 Trillion
  • Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 364,862 shares of INMB stock, worth $2.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
364,862
Previous 363,602 0.35%
Holding current value
$2.66 Million
Previous $1.7 Million 67.79%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$4.93 - $10.48 $6,211 - $13,204
1,260 Added 0.35%
364,862 $2.85 Million
Q4 2024

Feb 12, 2025
BUY
$4.4 - $6.43 $84,198 - $123,044
19,136 Added 5.56%
363,602 $1.7 Million
Q3 2024

Nov 12, 2024
BUY
$4.86 - $9.86 $103,333 - $209,643
21,262 Added 6.58%
344,466 $1.86 Million
Q2 2024

Aug 09, 2024
BUY
$7.15 - $11.84 $1.09 Million - $1.8 Million
152,402 Added 89.23%
323,204 $2.85 Million
Q1 2024

May 13, 2024
BUY
$10.53 - $14.01 $8,023 - $10,675
762 Added 0.45%
170,802 $2.01 Million
Q4 2023

Feb 13, 2024
BUY
$6.6 - $11.52 $19,384 - $33,834
2,937 Added 1.76%
170,040 $1.91 Million
Q3 2023

Nov 13, 2023
BUY
$6.61 - $10.9 $82,116 - $135,410
12,423 Added 8.03%
167,103 $1.13 Million
Q2 2023

Aug 11, 2023
BUY
$6.5 - $10.09 $71,649 - $111,222
11,023 Added 7.67%
154,680 $1.4 Million
Q1 2023

May 15, 2023
BUY
$6.01 - $10.18 $3,966 - $6,718
660 Added 0.46%
143,657 $928,000
Q4 2022

Feb 13, 2023
BUY
$6.13 - $7.96 $20,786 - $26,992
3,391 Added 2.43%
142,997 $906,000
Q3 2022

Nov 14, 2022
BUY
$6.04 - $10.44 $8,347 - $14,428
1,382 Added 1.0%
139,606 $865,000
Q2 2022

Aug 12, 2022
BUY
$5.48 - $8.97 $58,608 - $95,934
10,695 Added 8.39%
138,224 $1.22 Million
Q1 2022

May 13, 2022
BUY
$6.42 - $11.39 $59,442 - $105,460
9,259 Added 7.83%
127,529 $1.07 Million
Q4 2021

Feb 11, 2022
BUY
$9.97 - $20.38 $285,770 - $584,151
28,663 Added 31.99%
118,270 $1.21 Million
Q3 2021

Nov 12, 2021
BUY
$14.13 - $27.85 $223,437 - $440,392
15,813 Added 21.43%
89,607 $1.74 Million
Q2 2021

Aug 13, 2021
BUY
$9.29 - $19.33 $120,370 - $250,458
12,957 Added 21.3%
73,794 $1.3 Million
Q1 2021

May 12, 2021
BUY
$11.61 - $26.85 $315,583 - $729,836
27,182 Added 80.77%
60,837 $722,000
Q4 2020

Feb 12, 2021
BUY
$7.51 - $17.22 $27,276 - $62,543
3,632 Added 12.1%
33,655 $579,000
Q3 2020

Nov 13, 2020
BUY
$4.92 - $15.75 $147,713 - $472,862
30,023 New
30,023 $309,000

Others Institutions Holding INMB

# of Institutions
89
Shares Held
6.93M
Call Options Held
240K
Put Options Held
74.6K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $131M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email